Elcatonin
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Elcatonin
- Accession Number
- DB13742
- Description
- Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- Elcatonina
Pharmacology
- Indication
- Not Available
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Unlock Additional DataAcalabrutinib The therapeutic efficacy of Elcatonin can be decreased when used in combination with Acalabrutinib. Acebutolol The risk or severity of adverse effects can be increased when Acebutolol is combined with Elcatonin. Acetohexamide The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Elcatonin. Afatinib The therapeutic efficacy of Elcatonin can be decreased when used in combination with Afatinib. Aldesleukin The therapeutic efficacy of Elcatonin can be decreased when used in combination with Aldesleukin. Alectinib The therapeutic efficacy of Elcatonin can be decreased when used in combination with Alectinib. Alendronic acid The risk or severity of hypocalcemia can be increased when Elcatonin is combined with Alendronic acid. Aminosalicylic acid The therapeutic efficacy of Elcatonin can be decreased when used in combination with Aminosalicylic acid. Amitriptyline The risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptyline. Amitriptylinoxide The risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptylinoxide. Additional Data Available- Extended DescriptionExtended DescriptionAvailable for Purchase
Extended description of the mechanism of action and particular properties of each drug interaction.
Learn more - SeveritySeverityAvailable for Purchase
A severity rating for each drug interaction, from minor to major.
Learn more - Evidence LevelEvidence LevelAvailable for Purchase
A rating for the strength of the evidence supporting each drug interaction.
Learn more - ActionActionAvailable for Purchase
An effect category for each drug interaction. Know how this interaction affects the subject drug.
Learn more
- Food Interactions
- Not Available
Categories
- ATC Codes
- H05BA04 — Elcatonin
- Drug Categories
- Amino Acids, Peptides, and Proteins
- Anti-Parathyroid Agents
- Bone Density Conservation Agents
- Calcitonin Preparations
- Calcium Homeostasis
- Calcium-Regulating Hormones and Agents
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Nerve Tissue Proteins
- Neuropeptides
- Peptide Hormones
- Peptides
- Proteins
- Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
- Thyroid Products
- Classification
- Not classified
Chemical Identifiers
- UNII
- W0CMS474JK
- CAS number
- 60731-46-6
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- Not Available
- External Links
- Wikipedia
- Elcatonin
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created on June 23, 2017 14:47 / Updated on June 12, 2020 10:53
